We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| DXS International Plc | AQSE:DXSP | Aquis Stock Exchange | Ordinary Share | GB00B2Q6HZ92 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.75 | 2.00 | 3.50 | 2.75 | 2.50 | 2.75 | 0.00 | 16:29:59 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Feb 2023 to Feb 2025
TIDMDXSP
DXS INTERNATIONAL PLC
Notice of 2023 Annual General Meeting
The Board of DXS International plc (the "Company"), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, confirms that its Annual General Meeting is scheduled to take place on Thursday 30th November 2023 at Noon at the Pavilion Café, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.
For further information in relation to the AGM, shareholders should refer to the Notice of Annual General Meeting and the AGM Letter which have been despatched to shareholders. Copies of these documents, along with the Company's Annual Report for the year ended 30 April 2023, are available for download from the Company's website www.dxs-system.co.uk .
The Directors of DXS International plc accept responsibility for this announcement
Enquiries:
David Immelman (Chief Executive) 01252 719800 DXS International plc david@dxs-systems.com Suite 2, Second Floor Ash House, Tanshire Park Shackleford Road Elstead, Surrey GU8 6LB www.dxs-systems.co.uk Corporate Advisor David Papworth City & Merchant 0207 101 7676 Corporate Broker Hybridan LLP Claire Louise Noyce 020 3764 2341
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.
(END) Dow Jones Newswires
November 06, 2023 02:00 ET (07:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year DXS Chart |
1 Month DXS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
